Kura Oncology, Inc.

KURANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
9.08 USD
↗ 0.00 (0.00%)🟢PRE MARKET (AS OF 07:31 PM EDT)
🟢Market: OPEN
Open?$9.23
High?$9.56
Low?$9.08
Prev. Close?$9.07
Volume?692.5K
Avg. Volume?1.4M
VWAP?$9.30
Rel. Volume?0.50x
Bid / Ask
Bid?$7.91 × 100
Ask?$10.44 × 100
Spread?$2.53
Midpoint?$9.18
Valuation & Ratios
Market Cap?805.1M
Shares Out?88.8M
Float?79.9M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?4.62
EPS?-$3.14
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.06Strong
Quick Ratio?6.05Strong
Cash Ratio?1.27Strong
Debt/Equity?0.06Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A▾
P/B?
4.62FAIR▾
P/S?
11.93HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-2.2CHEAP▾
EV/Sales?
9.86HIGH▾
Returns & Efficiency
ROE?
-160.0%WEAK▾
ROA?
-37.7%WEAK▾
Cash Flow & Enterprise
FCF?$-70696000
Enterprise Value?$665.7M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Employees
260
Market Cap
821.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.kuraoncology.com
Listed
2015-08-25
Address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, CA 92121
Phone: (858) 500-8800
MarketsMoversWatchlist